Article info
Inflammatory bowel disease
Original article
Anti-NKG2D monoclonal antibody (NNC0142-0002) in active Crohn's disease: a randomised controlled trial
- Correspondence to Professor Matthieu Allez, Department of Gastroenterology, Hôpital Saint-Louis, 1, Avenue Claude Vellefaux, Paris 75010, France; matthieu.allez{at}aphp.fr
Citation
Anti-NKG2D monoclonal antibody (NNC0142-0002) in active Crohn's disease: a randomised controlled trial
Publication history
- Received March 9, 2016
- Revised June 30, 2016
- Accepted July 14, 2016
- First published August 3, 2016.
Online issue publication
October 09, 2017
Article Versions
- Previous version (3 August 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/